Abstract
Background: chronic osteomyelitis represents a persistent bone and bone marrow infection easy to diagnose in the presence of pain, erythema, swelling, and a draining sinus but more difficult to detect in the absence of the preceding features and with a painful orthopaedic prosthesis. Case Description: we report upon an elderly gentleman with myelodysplasia requiring revision surgery for a fractured prosthetic left knee. He had clinical, laboratory, and radiological features of chronic osteomyelitis that improved only with administration of granulocyte colony stimulating factor (G-CSF). Literature Review: G-CSF has been successfully employed to treat resistant osteomyelitis in three young patients with primary defects of monocyte and neutrophil killing. A randomized trial confirmed the efficacy of G-CSF in the treatment of chronic osteomyelitis in twenty patients with diabetic foot ulcers and a rat model confirmed the efficacy of G-CSF in acute osteomyelitis. Clinical Relevance: our case highlights the usefulness of G-CSF treatment for immune suppressed patients with resistant chronic osteomyelitis.
References
Calhoun JH, Manring MM (2005) Adult osteomyelitis. Infect Dis Clin North Am 19:765–786
Boogaerts MA, Nelissen V, Roelant C, Goossens W (1983) Blood neutrophil function in primary myelodysplastic syndrome. Brit J Haematol 55:217–227
Carulli G (1997) Effects of recombinant human granulocyte colony-stimulating factors administration on neutrophil phenotype and functions. Haematologica 82:606–616
Anderlini P, Champlin RE (2008) Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111:1767–1772
de Lalla F, Pellizzer G, Strazzabosco M, Martini Z, Du Jardin G, Lora L, Fabris P, Benedetti P, Erle G (2001) Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 45:1094–1098
Isotani H, Fukumoto Y, Kawamura H, Sasada M, Hattori K, Fujiwara T, Kobayashi Y (1997) Treatment with rhG-CSF for osteomyelitis in a patient with p47-phox-deficient chronic granulomatous disease. Ann Hematol 75:243–246
Dotis J, Panagopoulou P, Filioti J, Winn R, Toptsis C, Panteliadis C, Roilides E (2003) Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 31:121–124
Abu Jawdeh L, Haidar R, Bitar F, Mroueh S, Akel S, Nuwayri-Salti N, Dbaibo GS (2000) Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy. J Infect 41:97–100
Subasi M, Kapukaya A, Kesemenli C, Kaya H, Sari I (2001) Effect of granulocyte-macrophage colony-stimulating factor on treatment of acute osteomyelitis. An experimental investigation in rats. Arch Orthop Trauma Surg 121:170–173
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pearce, M.I., Cuthbert, A., Porter, G. et al. Improvement of Chronic Osteomyelitis After Granulocyte Colony Stimulating Factor. Indian J Hematol Blood Transfus 29, 48–51 (2013). https://doi.org/10.1007/s12288-011-0127-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-011-0127-6